The 2026 Swiss Medtech Award has reached its final phase: Medartis, Positrigo and Symbios are through to the finals.
Representing the diversity and technological capacity of the Swiss medtech industry, these three companies will compete for the award as well as prize money totaling CHF 50,000. The presentation ceremony will take place on 10 June at Swiss Medtech Day in Bern.
The award honours companies that contribute to the advancement of medical technology through new technologies and outstanding commitment. The winners are selected by an independent jury of high-calibre experts.
The finalists impressively demonstrate the synergy between entrepreneurial courage, technological expertise and practical medical experience.
Adrian Hunn, Director of Swiss Medtech
“We can be proud to have such companies here in Switzerland. They are prime examples of an industry that continues to define global standards,” says Adrian Hunn, Director of Swiss Medtech.
Medartis AG with headquarters in Basel, has been developing and manufacturing high-precision implant solutions for cranial surgery and for the upper and lower extremities – particularly hands and wrists – for almost 30 years. The family-owned company combines Swiss quality standards with medical expertise and a clear focus on innovation. The company collaborates with healthcare professionals to develop patient-oriented implant systems and digital planning tools that simplify surgical procedures and reduce the risk of complications. Medartis is also commited to surgical training and continuing education; helping to promote the transfer of knowledge in its core areas worldwide.
Positrigo AG, based in Zurich, is a well-established name in the field of neurological imaging. The company develops compact, user-friendly systems to support modern diagnostics. They can be applied directly in neurological practices and smaller treatment centres to help meet the growing demand for neurological disease assessment. The company develops and manufactures medical technology systems, works closely with clinical partners and is continuously broadening its technological and organisational expertise.
Symbios Orthopédie SA is a family-run company that exemplifies patient-specific orthopaedic solutions “Made in Switzerland”. Based in Yverdon-les-Bains, the company specialises in individualised hip and knee implants and combines clinical precision with industrial excellence. Symbios develops tailor-made solutions for each patient – contributing to a higher quality of life, as well as optimised efficiency for hospitals and the healthcare system. The company has recently invested in a new, technologically specialised production facility to manufacture patient-specific implants under controlled conditions.
Swiss Medtech first launched the Swiss Medtech Award in 2018. The prize money of CHF 50,000 – sponsored by the Sonova group and the Straumann group – recognises outstanding achievements within the Swiss medical technology industry.
The expert jury chaired by Dr. Gery Colombo, evaluates candidates based on patient benefit, improvements in healthcare, and technological pioneering spirit. The winning team is announced and honoured annually at Swiss Medtech Day the most important event for the Swiss medical technology industry.
11.05.2026.
